↓ Skip to main content

Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

Overview of attention for article published in BMC Pharmacology and Toxicology, May 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
Published in
BMC Pharmacology and Toxicology, May 2020
DOI 10.1186/s40360-020-00417-2
Pubmed ID
Authors

Christian Siebel, Gudrun Würthwein, Claudia Lanvers-Kaminsky, Nicolas André, Frank Berthold, Ilaria Castelli, Pascal Chastagner, François Doz, Martin English, Gabriele Escherich, Michael C. Frühwald, Norbert Graf, Andreas H. Groll, Antonio Ruggiero, Georg Hempel, Joachim Boos

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 8 22%
Student > Ph. D. Student 4 11%
Student > Bachelor 3 8%
Researcher 3 8%
Professor 2 6%
Other 4 11%
Unknown 12 33%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 9 25%
Medicine and Dentistry 6 17%
Nursing and Health Professions 3 8%
Biochemistry, Genetics and Molecular Biology 2 6%
Psychology 2 6%
Other 3 8%
Unknown 11 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2020.
All research outputs
#18,616,159
of 23,881,329 outputs
Outputs from BMC Pharmacology and Toxicology
#294
of 450 outputs
Outputs of similar age
#285,586
of 398,094 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#7
of 11 outputs
Altmetric has tracked 23,881,329 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 450 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 398,094 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.